Louisiana Opioid Deaths Fall 59% as Misuse Ranks Last — Metric Hygiene Check

ANALYSIS · September 7, 2026 (story date: Center Square / Just the News Sep 6, 2026; WBRZ Sep 2, 2026) Slug: louisiana-opioid-deaths-59-percent Package note: one ANALYSIS; homepage/story primary is Center Square via Just the News. Mortality/ED/Rx percentages are LDH figures as reported by Center Square and WBRZ — a standalone LDH HTML press release containing the exact “59%” string was not located this pass. Do not treat those percentages as independently recomputed from raw LODSS/CDC tables here. NSDUH rankings and prevalence estimates are LDH’s analysis of SAMHSA 2023–2024 survey data as reported in the same coverage.

Primary sources

• Homepage / story primary (independent): Louisiana opioid deaths fall 59% as misuse ranks last — Misty Castile | The Center Square · Published Sep 6, 2026 (Just the News)
• Local / prepared-statement quotes: Louisiana opioid deaths drop 59% from 2022 to 2025, outpacing national decline — WBRZ · Sep 2, 2026
• Reprint / Louisiana First via Yahoo: Opioid-related deaths in Louisiana drop 59% over three years, LDH says — Louisiana First / Nexstar · Copyright 2026
• LDH Opioid Surveillance hub (program context; not the 59% press release): Opioid Surveillance | Louisiana Department of Health
• Honesty flag: Standalone LDH HTML press release URL with the exact “59%” / “46.2%” / “52%” / “10%” string set was not located this pass. Attribute those figures as LDH-stated numbers as reported by Center Square / WBRZ / Louisiana First, not as independently recomputed from LODSS dashboards or CDC tables in this analysis. Other LDH HOPE/surveillance PDFs on the hub use different time windows (e.g., year-over-year 2023–2024 products) — do not conflate those with the 2022–2025 59% claim; mention only that other LDH surveillance products use different windows.

Core Tension

(1) Mortality/ED/Rx claims (LDH 2022–2025, preliminary 2025) are a different object from (2) NSDUH prevalence/ranking claims (2023–2024 survey). (3) “Misuse ranks last” holds as 51st of 51 on that survey measure but is not the same metric as deaths falling — both can be true. (4) Illegally made fentanyl is excluded from the federal misuse/OUD survey definitions — a material caveat. (5) 2025 mortality figures are preliminary and can revise. (6) The national 46.2% comparison is LDH-cited, not independently recomputed here. (7) Mental Health America rankings use an earlier data vintage than some LDH opioid trend windows. Attribute the 59%/52%/10% strings as LDH-as-reported (standalone LDH HTML PR not located this pass).

What the article claims / what sources say

A. Mortality, ED, and prescription trends (LDH 2022–2025; 2025 preliminary)

Per Center Square (JTN) and WBRZ, citing LDH:

1. Opioid-related deaths declined 59% from 2022 through 2025.
2. National opioid-related deaths declined 46.2% over the same period (LDH-cited national comparison; not independently recomputed here).
3. Opioid-related emergency department visits fell 52% in the same window.
4. Opioid prescriptions per 100 residents declined 10%.
5. 2025 data are preliminary (Center Square, WBRZ, Louisiana First) — figures can revise when finals post.
6. LDH Secretary Bruce Greenstein (prepared statement / quotes across outlets): “We’re seeing proven progress in behavioral health in Louisiana, and that is something worth celebrating.” WBRZ also quotes a longer Greenstein statement on reducing opioid deaths, prevention, and access to care. WBRZ/Louisiana First also quote LDH Office of Behavioral Health Assistant Secretary Holly Howat on patient-centered, data-driven, outcome-focused system building.

B. NSDUH prevalence and rankings (SAMHSA 2023–2024; LDH analysis)

Per Center Square (fullest NSDUH detail) and corroborating outlets:

1. LDH analysis of SAMHSA NSDUH 2023–2024: Louisiana ranked 51st for opioid misuse in the past year and 49th for opioid use disorder among the 50 states and D.C.
2. Survey base: responses from 1,920 Louisiana residents ages 12+ during 2023 and 2024; SAMHSA uses a small-area estimation (SAE) model with other data for state-level estimates.
3. Estimates (Center Square): 4.58% of ages 12+ misused opioids in the past year (~174,000 people); ages 26+: 4.99% (~148,000).
4. Estimated ~95,000 Louisiana residents with OUD, including ~85,000 ages 26+.
5. Federal opioid-misuse definition: heroin use or prescription opioid misuse — does not include illegally made fentanyl (IMF). OUD is similarly based on heroin or prescription opioid criteria. SAMHSA notes people may use fentanyl unknowingly when it is mixed into other illicit drugs — a material caveat for interpreting “last” on misuse while deaths (often fentanyl-involved in the broader epidemic) fall.
6. Treatment receipt: LDH said Louisiana ranked 5th for people receiving substance-use treatment in the past year.
7. SAMHSA need/receipt gap (Center Square): ~727,000 ages 12+ classified as needing SUD treatment in 2024; ~574,000 needing but not receiving; ~179,000 received treatment. “Needing treatment” = past-year SUD or received substance-use treatment that year; treatment includes inpatient/outpatient, MOUD/MAUD, telehealth, and carceral settings (per Center Square’s SAMHSA summary).
8. Across behavioral-health measures reviewed by LDH: average ranking 28th/51; top 20 on 13 measures. Center Square: ranked 2nd for perceptions of great risk from using cocaine monthly and trying heroin once or twice; 5th for receipt of substance-use treatment. WBRZ adds other ranks (e.g., 8th suicide plans, 9th MDE, 18th serious suicide thoughts) from the same LDH framing — keep as reported ranks, not recomputed.
9. Mental Health America 2025 State of Mental Health in America: Louisiana 27th overall (was 36th in the 2023 report). Center Square notes the 2025 MHA report primarily uses federal data collected through 2023 — an earlier vintage than some LDH opioid trend windows (2022–2025).
10. SAMHSA trend caution (Center Square): SAMHSA did not include opioid misuse, prescription opioid misuse, or OUD in comparisons between 2022–2023 and 2023–2024 state estimates because comparable measures were unavailable. Do not treat the latest misuse figures as a direct trend vs the prior survey wave.

C. Headline juxtaposition (“deaths fall” + “misuse ranks last”)

Center Square’s headline and lede pair a mortality trend (LDH 2022–2025) with a survey prevalence ranking (NSDUH 2023–2024 / LDH analysis). Those are different metrics and different time constructs. Both can be true at once: deaths can fall while past-year misuse prevalence still ranks 51st of 51. The juxtaposition is editorial tension, not an automatic contradiction. “Misuse ranks last” is accurate as 51st of 51 on the NSDUH misuse measure per LDH analysis — it is not the same claim as “deaths fell 59%.”

Claims check

Coverage / opposing views

Coverage is largely LDH-statement reprint and paraphrase, not a left/right fact war. Main analytical value is metric hygiene: separate mortality/ED/Rx trends from NSDUH prevalence ranks; respect IMF exclusion; respect preliminary 2025; respect SAMHSA’s no-comparable-misuse-trend caution; respect MHA’s earlier data vintage.

Ground News

• Not mapped this pass — no Ground News cluster link verified here. Do not invent one.

Outlet frames (with links)

• Center Square via Just the News (homepage primary): Fullest pairing of 59% death decline with 51st misuse / 49th OUD, IMF definitional caveat, treatment need/receipt gap, MHA vintage note, and SAMHSA non-comparability caution. Headline deliberately juxtaposes progress and “last” ranking. — https://justthenews.com/nation/states/center-square/louisiana-opioid-deaths-fall-59-misuse-ranks-last
• WBRZ (local, Sep 2, 2026): LDH-forward local frame; prepared Greenstein and Howat quotes; 59% / 46.2% / 52% / 10% / preliminary 2025; NSDUH average rank and selected top ranks; MHA climb 36th→27th. Less emphasis than Center Square on IMF exclusion and the “misuse ranks last” tension. — https://www.wbrz.com/news/louisiana-opioid-deaths-drop-59-from-2022-to-2025-outpacing-national-decline/
• Louisiana First via Yahoo (Nexstar reprint): Same LDH package — 59% vs national 46.2%, ED −52%, Rx −10%, preliminary 2025, Greenstein quote, NSDUH 51st/49th and 5th on treatment, MHA 27th. — https://www.yahoo.com/news/us/articles/opioid-related-deaths-louisiana-drop-175402226.html
• Other radio/web reprints (e.g., KVKI-style syndication): Search hits show Center Square–adjacent “59 percent since 2022” rewrites; treat as secondary amplification, not independent LDH recomputation.
• LDH Opioid Surveillance hub: Program and older fact-sheet/HOPE PDF inventory — context for surveillance capacity; not a substitute receipt for the 2022–2025 59% string this pass. — https://ldh.la.gov/bureau-of-health-informatics/opioidsurveillance

Coverage split note: Left/right fight is secondary. Outlets mostly transmit LDH’s progress narrative; Center Square uniquely foregrounds the deaths↓ vs misuse-rank-last tension and the IMF / survey-definition caveat that makes that tension interpretable rather than paradoxical.

Publish-ready ANALYSIS draft · Storm Wire · 2026-09-07 · for /analysis/louisiana-opioid-deaths-59-percent